REACH analysis shows benefits outweigh costs

Helsinki – An analysis by the European Chemicals Agency (ECHA) has found that the benefits of authorising hazardous chemicals under the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation outweigh costs by 15 to one.

The report, ‘Socio-economic impacts of REACH authorisations’, calculates that €281 million of health risks arise each year from the continued use of chemicals that require authorisation, but that costs would be around €4.2 billion if the REACH system were not in place.

ECHA’s report was intended to look into the costs of the continued use of 20 substances of very high concern (SVHCs), finding that although risks remain high, authorisation has considerably reduced harm to the environment and individuals. The authorisation requirements for SVHCs have led to many companies substituting them with safer alternatives.

By Gudrun Haindlmaier, AIT “As cities and rural areas across Europe face the mounting pressures of climate change, social fragmentation,…

Read Story

  23 January 2025, Enschede (The Netherlands) – The Horizon Europe project FertiCovery held its kick-off meeting in Enschede today,…

Read Story

    20 November 2024, Barcelona (Spain) – The Horizon Europe project MANTRA held its kick-off meeting today in Barcelona,…

Read Story
Arrow-up